EU Axis Labs BCAA Ethyl Ester 180 capsules
BCAA Ethyl Ester (BCAAE2™) Ester-Sorb™ Technology
Axis Labs® introduces BCAA Ethyl Ester (BCAAE2™); unlock your genetic
growth potential.
BCAAE2™ The Missing Anabolic Trigger
BCAAE2™ is the answer to improve your strength and muscle gains through
non-hormonal anabolic action. BCAAE2™ turns on the genes necessary for protein
synthesis and anabolism in your muscle for dramatic gains. BCAAE2™ also
increases the release of hormones such as growth hormone (GH), IGF-1, and
insulin, and can reduce cortisol secretion. BCAAE2™ also act as an
anti-catabolic, preventing your body from breaking down muscle tissue and using
it for energy. Eating a high protein diet is not enough to ensure that your body
is as anabolic as possible. BCAAE2™ will turn on your muscle anabolism machinery
and ensure that you can build slabs of new muscle.
Axis Labs® BCAAE2™ is a high potency formula containing the essential amino
acids L-Leucine, L-Valine and L-Isoleucine in a revolutionary ethyl ester form
and in a specific ratio to maximize their effectiveness. These three protein
sparing amino acids are known as branched chain amino acids, and play important
roles in protein synthesis and energy metabolism. Your body can not manufacture
its own branch chain amino acids, so they must be supplied through your diet.
Studies have shown that they are important for a variety of reasons including
muscle growth and recuperation. BCAAE2™ is truly at the forefront of
biochemically engineered supplements.
BCAA Ethyl Ester (BCAAE2™) Highlights:
• Potent anabolic activity to increase muscle growth
• Increased Protein Synthesis and Nitrogen Retention by turning on anabolic
genes
• Increase the important anabolic hormones insulin, GH, and IGF1
• Potent anti-catabolic activity to inhibit muscle breakdown
• Muscle sparing
• Glycogen sparing
• Improved and increased muscle recovery
• Lower lactate production
• Dramatically more potent than regular BCAA's and metabolites like
a-ketoisocaproic acid
• Unmatched BCAA absorption and utilization (bioavailability)
Anabolic Action:
Anabolic Action:Branched Chain Amino Acids (BCAA's) function by increasing
protein synthesis and nitrogen retention. Athletes and bodybuilders recognize
that protein synthesis and nitrogen retention are important anabolic functions
required for muscle growth, but many don’t realize how these compounds work.
BCAAE2™ turns on the genes necessary for protein synthesis and muscle
anabolism in muscle through non-hormonal anabolic action. They work by turning
on the main protein synthesis pathway called mTOR. mTOR is a very important
biochemical pathway that acts as the main signal to tell your muscle cells to
increase protein synthesis. When the mTOR pathway is activated it signals your
muscles to enter an anabolic state and start building muscle. This will allow
you to reach your genetic potential and build new slabs of muscle.
BCAAE2™ also increases the release of hormones such as insulin, growth
hormone (GH), and IGF-1. These hormones are the main anabolic hormones your body
uses to increase muscle protein synthesis, and when these hormones are high
there is a synergistic anabolic effect with sufficient BCAA. Axis Labs® BCAAE2™
will make sure that your body is in anabolic mode and fuel muscle growth like
nothing you have experienced before. Supplementing with BCAAE2TM is especially
important for people over the age of 40. Research shows that the muscle
anabolism that occurs following a meal high in protein is reduced in aged
muscle. Supplementing with BCAA can boost muscle anabolism and it will allow
older athletes to stay anabolic.
Anti-catabolic:
The benefits of supplementing with BCAAE2™ aren’t limited to muscle anabolism,
these compounds are hugely anti-catabolic and prevent you from wasting your hard
earned muscle. When you exercise strenuously your body is forced to uses
glycogen as fuel, when glycogen is used up your body begins to use muscle as
fuel. BCAAE2™ are unique in that they are primarily metabolized in the muscle.
When metabolized, BCAAE2™ provide the necessary amino acids that your body uses
for gluconeogenesis once the glycogen stores have been used up. Taking BCAAE2™
before strenuous exercise will insure that you don’t use your muscles for fuel.
Because of their anti-catabolic effect BCAA's may also help during extreme
dieting by preventing muscle tissue breakdown. Additionally, BCAAE2™ can aid in
recuperation by decreasing lactic acid levels in muscle cells. This is a great
benefit, and can an athlete reach new levels of workout intensity.
Bioavailablility:
The reason that BCAA supplementation has never been extremely popular among
athletes is that their benefit is difficult to realize when taken orally. The
problem with traditional BCAA's is that there is limited absorption through the
digestive tract, this has plagued other BCAA products since they were first
released. Regular BCAA's are degraded rapidly, leaving small amounts of the
original dose active. Because of the rapid breakdown of BCAA's, their ability to
promote muscle growth is limited. The limited potential of BCAA's has
historically been a problem, until now.
Axis Labs® BCAAE2™ are an amazing advance in scientific supplement
technology, that are much more effective than traditional BCAA supplements. The
Ester-Sorb™ technology we use allows the BCAA's to be much more bioavailable.
They are not broken down by the body as quickly as normal amino acids and they
can enter the blood stream from the GI tract more readily.
The reason BCAAE2™ is much more effective than other BCAA products is because
of the ethyl ester added to each BCAA molecule. In fact, BCAAE2™ utilizes the
same Ester-Sorb™ ethyl ester delivery technology that makes our NE2™ many times
more effective than regular L-Arginine. The ethyl ester makes the BCAA’s less
polar and therefore more easily absorbed in the digestive tract. Because of this
design, each amino acid can pass through the intestine largely intact. The ethyl
ester also protects the BCAA molecules from rapid degradation, making them much
more effective in smaller doses than other BCAA products. BCAAE2™ is superior in
design to all other current BCAA products on the market, including products
containing BCAA metabolites like a-ketoisocaproic acid and after one month of
use, you will never train without them again. BCAAE2™ provides a much more
effective and efficient way to experience the benefits of BCAA supplementation.
If you are ready to take training to the next level and record muscle growth,
then you are ready for BCAAE2™.
Demand more from your BCAA's. Demand Axis Labs® BCAA Ethyl Ester!
Supplement Facts
Serving Size: 4 Capsules
Servings per Container: 45 |
|
|
Amount Per Serving |
%DV* |
|
BCAAE2™ Matrix |
3,200mg |
|
|
L-Leucine Ethyl Ester HCI |
1,600mg |
† |
|
L-Isoleucine Ethyl Ester HCI |
800mg |
† |
|
L-Valine Ethyl Ester HCI |
800mg |
† |
* Daily values (DV) are based on a 2000 calorie diet
† Daily value (DV) not established |
Other Ingredients: Magnesium stearate, gelatin.
Directions: As a dietary supplement, take 2 to 4 capsules 1 to 3 times
daily, preferably prior to and after exercise and/or with meals.
Store in a cool place. Protect from heat, light and moisture.
WARNING: KEEP OUT OF REACH OF CHILDREN. This product is not intended for
anyone under the age of 16. Consult your physician before using any dietary
supplement. Do not take this product if you have any medical condition and/or
are taking any prescription medication(s). Discontinue use if experiencing any
adverse side effects.
Manufactured with pride in the USA.
BCAAE2™ and Ester-Sorb™ registered trademark of Axis Labs®.
* These statements have not been evaluated by the FDA. This product is not
intended to diagnose, treat, cure or prevent any disease.
References:
Anthony, J. C., T. G. Anthony, S. R. Kimball, et al. 2001. Signaling pathways
involved in translational control of protein synthesis in skeletal muscle by
leucine. J Nutr 131(3): 856S-860S.
Anthony, J. C., T. G. Anthony and D. K. Layman 1999. Leucine supplementation
enhances skeletal muscle recovery in rats following exercise. J Nutr 129(6):
1102-6.
Bassit, R. A., L. A. Sawada, R. F. Bacurau, et al. 2000. The effect of BCAA
supplementation upon the immune response of triathletes. Med Sci Sports Exerc
32(7): 1214-9.
Beugnet, A., A. R. Tee, P. M. Taylor, et al. 2003. Regulation of targets of mTOR
(mammalian target of rapamycin) signalling by intracellular amino acid
availability. Biochem J 372(Pt 2): 555-66.
Bigard, A. X., P. Lavier, L. Ullmann, et al. 1996. Branched-chain amino acid
supplementation during repeated prolonged skiing exercises at altitude. Int J
Sport Nutr 6(3): 295-306.
Blomstrand, E. 2001. Amino acids and central fatigue. Amino Acids 20(1): 25-34.
Blomstrand, E. 2006. A role for branched-chain amino acids in reducing central
fatigue. J Nutr 136(2): 544S-547S.
Blomstrand, E., J. Eliasson, H. K. Karlsson, et al. 2006. Branched-chain amino
acids activate key enzymes in protein synthesis after physical exercise. J Nutr
136(1 Suppl): 269S-73S.
Blomstrand, E., P. Hassmen, B. Ekblom, et al. 1991. Administration of
branched-chain amino acids during sustained exercise--effects on performance and
on plasma concentration of some amino acids. Eur J Appl Physiol Occup Physiol
63(2): 83-8.
Blomstrand, E., P. Hassmen and E. A. Newsholme 1991. Effect of branched-chain
amino acid supplementation on mental performance. Acta Physiol Scand 143(2):
225-6.
Blomstrand, E. and B. Saltin 2001. BCAA intake affects protein metabolism in
muscle after but not during exercise in humans. Am J Physiol Endocrinol Metab
281(2): E365-74.
Calvey, H., M. Davis and R. Williams 1985. Controlled trial of nutritional
supplementation, with and without branched chain amino acid enrichment, in
treatment of acute alcoholic hepatitis. J Hepatol 1(2): 141-51.
Campbell, W. W., M. C. Crim, V. R. Young, et al. 1995. Effects of resistance
training and dietary protein intake on protein metabolism in older adults. Am J
Physiol 268(6 Pt 1): E1143-53.
Chawla, W., Stackhouse, J., Wadsworth, A. 1975. Efficiency of a-Ketoisocaproic
Acid as a Substitute for Leucine in the Diet of the Growing Rat. J Nutr 105(6):
798-803.
Cota, D., K. Proulx, K. A. Smith, et al. 2006. Hypothalamic mTOR signaling
regulates food intake. Science 312(5775): 927-30.
De Palo, E. F., R. Gatti, E. Cappellin, et al. 2001. Plasma lactate, GH and
GH-binding protein levels in exercise following BCAA supplementation in
athletes. Amino Acids 20(1): 1-11.
Garlick, P. J., M. A. McNurlan and C. S. Patlak 1999. Adaptation of protein
metabolism in relation to limits to high dietary protein intake. Eur J Clin Nutr
53 Suppl 1: S34-43.
Guillet, C., M. Prod'homme, M. Balage, et al. 2004. Impaired anabolic response
of muscle protein synthesis is associated with S6K1 dysregulation in elderly
humans. Faseb J 18(13): 1586-7.
Kawamura, I., H. Sato, S. Ogoshi, et al. 1985. Use of an intravenous branched
chain amino acid enriched diet in the tumor-bearing rat. Jpn J Surg 15(6):
471-6.
Kimball, S. R. and L. S. Jefferson 2006. New functions for amino acids: effects
on gene transcription and translation. Am J Clin Nutr 83(2): 500S-507S.
Kimball, S. R. and L. S. Jefferson 2006. Signaling pathways and molecular
mechanisms through which branched-chain amino acids mediate translational
control of protein synthesis. J Nutr 136(1 Suppl): 227S-31S.
Laviano, A., M. M. Meguid, A. Inui, et al. 2006. Role of leucine in regulating
food intake. Science 313(5791): 1236-8; author reply 1236-8.
Layman, D. K. 2002. Role of leucine in protein metabolism during exercise and
recovery. Can J Appl Physiol 27(6): 646-63.
Layman, D. K. 2003. The role of leucine in weight loss diets and glucose
homeostasis. J Nutr 133(1): 261S-267S.
Lo, H. C. and D. M. Ney 1996. GH and IGF-I differentially increase protein
synthesis in skeletal muscle and jejunum of parenterally fed rats. Am J Physiol
271(5 Pt 1): E872-8.
Lobley, G. E., A. Connell, E. Milne, et al. 1990. Muscle protein synthesis in
response to testosterone administration in wether lambs. Br J Nutr 64(3):
691-704.
Lynch, C. J. 2001. Role of leucine in the regulation of mTOR by amino acids:
revelations from structure-activity studies. J Nutr 131(3): 861S-865S.
Lynch, C. J., B. Gern, C. Lloyd, et al. 2006. Leucine in food mediates some of
the postprandial rise in plasma leptin concentrations. Am J Physiol Endocrinol
Metab 291(3): E621-30.
Lynch, C. J., B. Halle, H. Fujii, et al. 2003. Potential role of leucine
metabolism in the leucine-signaling pathway involving mTOR. Am J Physiol
Endocrinol Metab 285(4): E854-63.
Lynch, C. J., B. J. Patson, J. Anthony, et al. 2002. Leucine is a direct-acting
nutrient signal that regulates protein synthesis in adipose tissue. Am J Physiol
Endocrinol Metab 283(3): E503-13.
MacLean, D. A., T. E. Graham and B. Saltin 1994. Branched-chain amino acids
augment ammonia metabolism while attenuating protein breakdown during exercise.
Am J Physiol 267(6 Pt 1): E1010-22.
Marchesini, G., R. Marzocchi, M. Noia, et al. 2005. Branched-chain amino acid
supplementation in patients with liver diseases. J Nutr 135(6 Suppl):
1596S-601S.
Mero, A. 1999. Leucine supplementation and intensive training. Sports Med 27(6):
347-58.
Mitch, W. E. 1980. Metabolism and metabolic effects of ketoacids. Am J Clin Nutr
33(7): 1642-8.
Mittleman, K. D., M. R. Ricci and S. P. Bailey 1998. Branched-chain amino acids
prolong exercise during heat stress in men and women. Med Sci Sports Exerc
30(1): 83-91.
Mourier, A., A. X. Bigard, E. de Kerviler, et al. 1997. Combined effects of
caloric restriction and branched-chain amino acid supplementation on body
composition and exercise performance in elite wrestlers. Int J Sports Med 18(1):
47-55.
Norton, L. E. and D. K. Layman 2006. Leucine regulates translation initiation of
protein synthesis in skeletal muscle after exercise. J Nutr 136(2): 533S-537S.
Ogata, E. S., S. K. Foung and M. A. Holliday 1978. The effects of starvation and
refeeding on muscle protein synthesis and catabolism in the young rat. J Nutr
108(5): 759-65.
Petibois, C., G. Cazorla, J. R. Poortmans, et al. 2002. Biochemical aspects of
overtraining in endurance sports: a review. Sports Med 32(13): 867-78.
Platell, C., S. E. Kong, R. McCauley, et al. 2000. Branched-chain amino acids. J
Gastroenterol Hepatol 15(7): 706-17.
Proud, C. G. 2004. Role of mTOR signalling in the control of translation
initiation and elongation by nutrients. Curr Top Microbiol Immunol 279: 215-44.
Proud, C. G., X. Wang, J. V. Patel, et al. 2001. Interplay between insulin and
nutrients in the regulation of translation factors. Biochem Soc Trans 29(Pt 4):
541-7.
Rennie, M. J., J. Bohe, K. Smith, et al. 2006. Branched-chain amino acids as
fuels and anabolic signals in human muscle. J Nutr 136(1 Suppl): 264S-8S.
Riazi, R., M. Rafii, L. J. Wykes, et al. 2003. Valine may be the first limiting
branched-chain amino acid in egg protein in men. J Nutr 133(11): 3533-9.
Riazi, R., L. J. Wykes, R. O. Ball, et al. 2003. The total branched-chain amino
acid requirement in young healthy adult men determined by indicator amino acid
oxidation by use of L-[1-13C]phenylalanine. J Nutr 133(5): 1383-9.
Sans, M. D., M. Tashiro, N. L. Vogel, et al. 2006. Leucine activates pancreatic
translational machinery in rats and mice through mTOR independently of CCK and
insulin. J Nutr 136(7): 1792-9.
Schliess, F., L. Richter, S. vom Dahl, et al. 2006. Cell hydration and
mTOR-dependent signalling. Acta Physiol (Oxf) 187(1-2): 223-9.
Sherwin, R. S. 1981. The effect of ketone bodies and dietary carbohydrate intake
on protein metabolism. Acta Chir Scand Suppl 507: 30-40.
Shimomura, Y., T. Murakami, N. Nakai, et al. 2000. Suppression of glycogen
consumption during acute exercise by dietary branched-chain amino acids in rats.
J Nutr Sci Vitaminol (Tokyo) 46(2): 71-7.
Silk, D. B., J. E. Hegarty, P. D. Fairclough, et al. 1982. Characterization and
nutritional significance of peptide transport in man. Ann Nutr Metab 26(6):
337-52.
Sokal, E. M., M. C. Baudoux, E. Collette, et al. 1996. Branched chain amino
acids improve body composition and nitrogen balance in a rat model of extra
hepatic biliary atresia. Pediatr Res 40(1): 66-71.
Stein, T. P., M. R. Donaldson, M. J. Leskiw, et al. 2003. Branched-chain amino
acid supplementation during bed rest: effect on recovery. J Appl Physiol 94(4):
1345-52.
Stipanuk, M. H. 2007. Leucine and protein synthesis: mTOR and beyond. Nutr Rev
65(3): 122-9.
Talvas, J., A. Obled, P. Fafournoux, et al. 2006. Regulation of protein
synthesis by leucine starvation involves distinct mechanisms in mouse C2C12
myoblasts and myotubes. J Nutr 136(6): 1466-71.
Tarnopolsky, M. A., S. A. Atkinson, J. D. MacDougall, et al. 1992. Evaluation of
protein requirements for trained strength athletes. J Appl Physiol 73(5):
1986-95.
Tipton, K. D., A. A. Ferrando, S. M. Phillips, et al. 1999. Postexercise net
protein synthesis in human muscle from orally administered amino acids. Am J
Physiol 276(4 Pt 1): E628-34.
Tokunaga, C., K. Yoshino and K. Yonezawa 2004. mTOR integrates amino acid- and
energy-sensing pathways. Biochem Biophys Res Commun 313(2): 443-6.
Zhang, Y., K. Guo, R. E. Leblanc, et al. 2007. Increasing dietary leucine intake
reduces diet-induced obesity and improves glucose and cholesterol metabolism in
mice via multi-mechanisms. Diabetes.
|
